Latest news
Loading news…
Dynavax Technologies is a biopharmaceutical company discovering and developing novel products to prevent and treat infectious diseases.
Dynavax Technologies was acquired by Sanofi in 2025 for $2B.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Investments
1
1 exits
Monthly Visits
Available in Pro Contacts
352
Patents
67
31 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 11
- Active products
- 20
- Patents granted
- 67
- Trademarks
- 31
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $7M
Investor Activity
- Investments
- 1
- Lead investments
- 1
- Portfolio orgs
- 1
- Exits
- 1
- Exits via IPO
- 1
Company Info
- Org types
- company, investor
- HQ
- Berkeley, California, United States
Signals & Scores
- Trend (7d)
- -0.2
- Trend (30d)
- 0.6
- Trend (90d)
- -0.7
Investments by Dynavax Technologies
Loading columns…
0 of 0Show
Page 1 / 1
Acquisitions by Dynavax Technologies
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Dynavax Technologies
SVP and CFO
352
professional contacts at Dynavax Technologies
Contact execs at Dynavax Technologies →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Dynavax Technologies
Loading news…
FAQs about Dynavax Technologies
People who checked this page also checked these
Sectors Dynavax Technologies invests & acquires in
Browse the full Acquirezy directory.